The pharmaceutical arm of giant South Korean conglomerate Samsung was fined Wednesday for alleged accounting breaches amounting to nearly $4 billion, and had dealings in its shares suspended...
from NDTV News - World-news https://ift.tt/2K1CMpK
ref=da&site=blogger">IFTTT
No comments:
Post a Comment